国内首个用于支架内再狭窄适应症的雷帕霉素药球获批上市

美港电讯2024-10-22

【国内首个用于支架内再狭窄适应症的雷帕霉素药球获批上市】金十数据10月22日讯，近日，由蓝帆医疗心脑血管事业部子公司吉威医疗研发生产的创新医疗器械——柏腾™“优美莫司涂层冠状动脉球囊扩张导管”（BA9DCB，国械注准20223031247）获国家药监局批准注册新适应症，成为国内首款获批用于支架内再狭窄（ISR）的雷帕霉素类药物涂层球囊。大量临床试验表明，药物涂层球囊（DCB）作为治疗支架内再狭窄（...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2477878849?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-22 11:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2477878849","market":"hk","top_or_hot":-1,"title":"国内首个用于支架内再狭窄适应症的雷帕霉素药球获批上市","media":"美港电讯","content":"<html><body><div>\n<p>【国内首个用于支架内再狭窄适应症的雷帕霉素药球获批上市】金十数据10月22日讯，近日，由蓝帆医疗心脑血管事业部子公司吉威医疗研发生产的创新医疗器械——柏腾™“优美莫司涂层冠状动脉球囊扩张导管”（BA9DCB，国械注准20223031247）获国家药监局批准注册新适应症，成为国内首款获批用于支架内再狭窄（ISR）的雷帕霉素类药物涂层球囊。大量临床试验表明，药物涂层球囊（DCB）作为治疗支架内再狭窄（...</p>\n<a href=\"https://www.ushknews.com/\">网页链接</a>\n</div>\n</body></html>","source":"live_meigang","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>国内首个用于支架内再狭窄适应症的雷帕霉素药球获批上市</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国内首个用于支架内再狭窄适应症的雷帕霉素药球获批上市\n</h2>\n<h4 class=\"meta\">\n\n\n2024-10-22 11:53 北京时间   <a href=\"https://www.ushknews.com/\"><strong>美港电讯</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>【国内首个用于支架内再狭窄适应症的雷帕霉素药球获批上市】金十数据10月22日讯，近日，由蓝帆医疗心脑血管事业部子公司吉威医疗研发生产的创新医疗器械——柏腾™“优美莫司涂层冠状动脉球囊扩张导管”（BA9DCB，国械注准20223031247）获国家药监局批准注册新适应症，成为国内首款获批用于支架内再狭窄（ISR）的雷帕霉素类药物涂层球囊。大量临床试验表明，药物涂层球囊（DCB）作为治疗支架内再狭窄（...</p>\n<a href=\"https://www.ushknews.com/\">网页链接</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0114","symbol_name":"健康中国","start_time":0,"source_url":"https://www.ushknews.com/","article_id":"2477878849","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2477878849","pubTimestamp":1729569215,"columns":[],"sourceInfo":{"source_id":"live_meigang","name":"美港电讯"},"weMediaInfo":null,"summary":"【国内首个用于支架内再狭窄适应症的雷帕霉素药球获批上市】金十数据10月22日讯，近日，由蓝帆医疗心脑血管事业部子公司吉威医疗研发生产的创新医疗器械——柏腾™“优美莫司涂层冠状动脉球囊扩张导管”（BA9","collect":0,"end_time":0,"defaultTopTitle":"ushknews.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159883":"医疗器械","159891":"医疗","BK0114":"健康中国","BK1576":"医药外包概念","BK1574":"生物医药B类股","BK1141":"生命科学工具和服务","03347":"泰格医药","BK1222":"医疗保健用品","09996":"沛嘉医疗-B","BK1583":"高瓴概念","002382":"蓝帆医疗","09997":"康基医疗","BK0251":"专用设备","BK0077":"质押式回购","BK1100":"医疗保健设备"},"translate_title":"The first rapamycin drug ball for in-stent restenosis indication in China was approved for marketing","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"159891":1,"002382":1,"03347":1,"09996":1,"09997":1},"content_text":"【国内首个用于支架内再狭窄适应症的雷帕霉素药球获批上市】金十数据10月22日讯，近日，由蓝帆医疗心脑血管事业部子公司吉威医疗研发生产的创新医疗器械——柏腾™“优美莫司涂层冠状动脉球囊扩张导管”（BA9DCB，国械注准20223031247）获国家药监局批准注册新适应症，成为国内首款获批用于支架内再狭窄（ISR）的雷帕霉素类药物涂层球囊。大量临床试验表明，药物涂层球囊（DCB）作为治疗支架内再狭窄（ISR）的有效手段，相较于传统ISR治疗方法展现出了显著优势。","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.5","shortVersion":"4.31.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477878849"}